Neuromics: Matters for serious thought…

MIlabs introduces multimodal Neuromics Imaging

Major recent improvements in a number of imaging techniques enable studying the brain in ways that could not be considered previously. Today, with MILabs’ new multimodality neuromics platform, researchers have well-developed and complementary tools for in vivo structural and functional imaging of the rodent brain in action.  More specifically, now you can:

  • Examine the dynamic nature of vascular responses and brain perfusion.
  • Study neuroreceptor kinetics at ultra-high resolution with SPECT in species ranging from mice to large non-human primates.
  • Gain new insights into brain (dys)functions by simultaneously performing spatially and temporally co-registered PET and SPECT acquisitions.
  • Probe neurodegeneration with in vivo bioluminescence and fluorescence imaging.
  • Replace labor-intensive and error-prone neural tissue examinations by automated 3D multi-tracer autoradiography.
  • Perform SPECT/CT and PET/CT at ultra-high resolutions critical for studying structures that fall well below the threshold of other preclinical hybrid scanners.

Best of all, you just need one single imaging platform, the MILabs PET/SPECT/OI/CT (VECTor-OI/CT) system, to make this all possible.

 
MILabs’ VECTor-OI/CT system makes anatomical, functional and molecular neuromics evaluation possible in a completely non-invasive way.
Read more about exciting brain imaging applications:

 
Meet us at upcoming conferences
 
G-SPECT is not available for clinical use. Sale for such use depends on local (pre)market approval, including FDA and CE certifications.

Copyright © 2017 MILabs, All rights reserved.

www.milabs.com

unsubscribe from this list    update subscription preferences